GlycoMimetics Inc (GLYC)
0.2631
+0.01
(+5.24%)
USD |
NASDAQ |
Jun 21, 16:00
0.2699
+0.01
(+2.58%)
After-Hours: 20:00
GlycoMimetics Net Income (Annual): -36.90M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -36.90M |
| December 31, 2022 | -46.69M |
| December 31, 2021 | -63.43M |
| December 31, 2020 | -51.03M |
| December 31, 2019 | -57.89M |
| December 31, 2018 | -48.27M |
| December 31, 2017 | -33.28M |
| Date | Value |
|---|---|
| December 31, 2016 | -31.81M |
| December 31, 2015 | -12.77M |
| December 31, 2014 | -11.12M |
| December 31, 2013 | -10.61M |
| December 31, 2012 | 3.656M |
| December 31, 2011 | -6.113M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-63.43M
Minimum
2021
-36.90M
Maximum
2023
-51.19M
Average
-51.03M
Median
2020
Net Income (Annual) Benchmarks
| Altimmune Inc | -88.45M |
| Lyell Immunopharma Inc | -234.63M |
| Amicus Therapeutics Inc | -151.58M |
| InfuSystems Holdings Inc | 0.872M |
| Nanoviricides Inc | -8.589M |